Pfizer's First Quarterly Loss in Two Years
Pfizer reported its first quarterly loss since 2019, attributing it to declining demand for its COVID-19 products. The company incurred a $5.6 billion non-cash write-off in the third quarter. Despite the loss, Pfizer aims to offset revenue declines through new vaccine approvals and portfolio expansions.